New in the Marketplace


The following table contains a summary of product launches and approvals identified in international markets in recent weeks.

Generic name Trade name (Company) Indication/category Country
Balsalazide (L) Colazal (Salix Pharmaceuticals) Treatment of ulcerative colitis US
Caspofungin (A) Cancidas (Merck & Co.) Treatment of invasive aspergillosis US
Crotalid antivenin (L) CroFab (Protherics) Treatment of snake bites US
Linezolid (A) Zyvox (Pharmacia Corporation) Treatment of Gram-positive infections UK
Pneumococcal conjugate vaccine (A) Prevenar (Wyeth-Lederle Vaccines) Prevention of invasive pneumococcal disease EU
Ziprasidone (A) NA (Pfizer) Treatment of schizophrenia US

A = approved; L = launched; EU = European Union; NA = not available.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.